Cargando…
Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma
BACKGROUND & AIMS: Microvascular invasion (MVI) is a critical prognostic factor for operable hepatocellular carcinoma (HCC). This study aimed to explore the performance of circulating tumour DNA (ctDNA) in evaluating MVI status preoperatively. METHODS: Seventy‐three HCC patients were enrolled an...
Autores principales: | Wang, Dong, Xu, Yaping, Goldstein, Jennifer B., Ye, Ke, Hu, Xi, Xiao, Liang, Li, Lifeng, Chang, Lianpeng, Guan, Yanfang, Long, Guo, He, Qiongzhi, Yi, Xin, Zhang, Jianjun, Wang, Zhiming, Xia, Xuefeng, Zhou, Ledu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496978/ https://www.ncbi.nlm.nih.gov/pubmed/32279416 http://dx.doi.org/10.1111/liv.14463 |
Ejemplares similares
-
Predicting microvascular invasion in hepatocellular carcinoma: A dual‐institution study on gadoxetate disodium‐enhanced MRI
por: Jiang, Hanyu, et al.
Publicado: (2022) -
Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab
por: Reig, Maria, et al.
Publicado: (2020) -
Rapid automated diagnosis of primary hepatic tumour by mass spectrometry and artificial intelligence
por: Giordano, Silvia, et al.
Publicado: (2020) -
Hypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma
por: Gao, Xu-dong, et al.
Publicado: (2014) -
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
por: Vithayathil, Mathew, et al.
Publicado: (2022)